INCR
InterCure Ltd.
Price Chart
Latest Quote
$4.48
+0.21 (+4.92%)
Current Price
| Previous Close | $4.27 |
| Open | $4.49 |
| Day High | $4.49 |
| Day Low | $4.47 |
| Volume | 498 |
Stock Information
Note: Financial values converted from ILS to USD
| Shares Outstanding | 15.00M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $67.22M |
| EPS (TTM) | $-0.95 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Book/sh | $7.59 |
| Employees | 285 |
Financial Ratios
| Quick Ratio | 0.91 |
| Current Ratio | 1.48 |
| Debt/Eq | 46.17 |
Returns & Margins
| ROA | -5.78% |
| ROE | -9.27% |
| Gross Margin | 15.06% |
| Profit Margin | -13.22% |
Ownership
| Insider Ownership | 38.21% |
| Institutional Ownership | 0.96% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.03 |
| P/B | 0.59 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $4.85 |
| SMA50 | $5.11 |
| SMA200 | $4.63 |
| RSI | 31.21 |
| ATR | 0.2617 |
| Shares Float | 6.65M |
| Short Float | 0.04% |
| Short Ratio | 0.60 |
| Volatility | 0.64 |
| Rel Volume | 0.13 |
Performance History
| Week | +1.13% |
| Month | -11.98% |
| Quarter | +2.28% |
| 6 Months | +3.34% |
| YTD | -13.01% |
| Year | -40.66% |
| 3 Years | -23.42% |
| 5 Years | -87.22% |
| 10 Years | -64.30% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $4.48 | 498 |
| 2026-10-26 | $4.27 | 3,900 |
| 2026-10-23 | $4.53 | 2,000 |
| 2026-10-22 | $4.44 | 3,500 |
| 2026-10-21 | $4.42 | 5,400 |
| 2026-10-20 | $4.43 | 2,500 |
| 2026-10-19 | $4.46 | 1,800 |
| 2026-10-16 | $4.57 | 5,200 |
| 2026-10-15 | $4.65 | 6,100 |
| 2026-10-14 | $4.69 | 9,500 |
| 2026-10-13 | $5.03 | 6,900 |
| 2026-10-12 | $4.95 | 6,700 |
| 2026-10-09 | $5.17 | 500 |
| 2026-10-08 | $5.03 | 3,300 |
| 2026-10-07 | $5.13 | 7,800 |
| 2026-10-06 | $5.32 | 2,600 |
| 2026-10-05 | $5.45 | 1,500 |
| 2026-10-02 | $5.42 | 2,800 |
| 2026-10-01 | $5.37 | 2,000 |
| 2026-09-30 | $5.27 | 3,600 |
| 2026-09-29 | $5.23 | 2,300 |
| 2026-09-28 | $5.09 | 2,100 |
About InterCure Ltd.
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
đ° Latest News
No news articles available at the moment. Check back later for updates on INCR.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $74,274,498 | $65,761,324 | $79,849,849 | $73,649,478 |
| Cost Of Revenue | $77,197,340 | $67,945,150 | $81,574,436 | $76,084,093 |
| Total Revenue | $88,004,426 | $77,792,070 | $115,803,989 | $126,594,791 |
| Operating Revenue | $88,004,426 | $77,792,070 | $115,803,989 | $126,594,791 |
| Expenses | ||||
| Interest Expense | $6,403,934 | $6,724,098 | $7,888,154 | $4,784,223 |
| Total Expenses | $85,811,481 | $92,466,857 | $103,559,909 | $113,175,907 |
| Rent Expense Supplemental | $1,624,923 | $1,887,763 | $1,940,527 | $1,953,229 |
| Other Income Expense | $-10,604,175 | $-7,223,072 | $-25,797,478 | $5,456,470 |
| Other Non Operating Income Expenses | $-1,370,224 | $-3,236,491 | $-2,412,793 | $-316,256 |
| Net Non Operating Interest Income Expense | $-5,953,164 | $-6,543,986 | $-6,407,191 | $-4,595,968 |
| Total Other Finance Cost | $55,695 | $699,280 | $269,680 | $86,636 |
| Interest Expense Non Operating | $6,403,934 | $6,724,098 | $7,888,154 | $4,784,223 |
| Operating Expense | $8,614,142 | $24,521,707 | $21,985,473 | $37,091,814 |
| Other Operating Expenses | $-22,723,186 | $-10,714,588 | $-9,797,088 | - |
| Selling And Marketing Expense | $6,598,703 | $7,070,970 | $7,144,904 | $6,614,337 |
| General And Administrative Expense | $19,591,896 | $20,493,436 | $20,942,578 | $25,082,239 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-11,630,785 | $-22,080,903 | $-20,180,112 | $14,597,596 |
| Net Interest Income | $-5,953,164 | $-6,543,986 | $-6,407,191 | $-4,595,968 |
| Interest Income | $506,465 | $879,393 | $1,750,643 | $274,892 |
| Normalized Income | $-3,848,822 | $-18,757,664 | $-2,173,905 | $8,837,116 |
| Net Income From Continuing And Discontinued Operation | $-11,630,785 | $-22,080,903 | $-20,180,112 | $14,597,596 |
| Total Operating Income As Reported | $-8,873,400 | $-21,889,717 | $-13,538,416 | $16,489,268 |
| Net Income Common Stockholders | $-11,630,785 | $-22,080,903 | $-20,180,112 | $14,597,596 |
| Net Income | $-11,630,785 | $-22,080,903 | $-20,180,112 | $14,597,596 |
| Net Income Including Noncontrolling Interests | $-11,980,588 | $-23,708,757 | $-20,692,765 | $14,249,096 |
| Net Income Continuous Operations | $-11,980,588 | $-23,708,757 | $-20,692,765 | $14,249,096 |
| Pretax Income | $-14,364,394 | $-28,441,194 | $-19,960,589 | $14,279,386 |
| Special Income Charges | $0 | $0 | $-22,394,228 | $3,443,312 |
| Earnings From Equity Interest | $96,408 | $0 | $0 | - |
| Interest Income Non Operating | $506,465 | $879,393 | $1,750,643 | $274,892 |
| Operating Income | $2,192,945 | $-14,674,787 | $12,244,080 | $13,418,884 |
| Depreciation Amortization Depletion Income Statement | $2,662,280 | $2,822,525 | $2,563,593 | $1,375,761 |
| Depreciation And Amortization In Income Statement | $2,662,280 | $2,822,525 | $2,563,593 | $1,375,761 |
| Depreciation Income Statement | $2,662,280 | $2,822,525 | $2,563,593 | $1,375,761 |
| Gross Profit | $10,807,087 | $9,846,920 | $34,229,553 | $50,510,697 |
| Per Share | ||||
| Diluted EPS | - | - | $-0.44 | $0.32 |
| Basic EPS | - | - | $-0.44 | $0.32 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,548,396 | $-663,342 | $-5,378,477 | $12,245 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $6,955,020 | $-12,724,163 | $15,600,429 | $17,101,260 |
| Total Unusual Items | $-9,330,358 | $-3,986,581 | $-23,384,685 | $5,772,726 |
| Total Unusual Items Excluding Goodwill | $-9,330,358 | $-3,986,581 | $-23,384,685 | $5,772,726 |
| Reconciled Depreciation | $5,585,122 | $5,006,351 | $4,288,180 | $3,810,377 |
| EBITDA (Bullshit earnings) | $-2,375,338 | $-16,710,744 | $-7,784,255 | $22,873,985 |
| EBIT | $-7,960,460 | $-21,717,095 | $-12,072,435 | $19,063,609 |
| Diluted NI Availto Com Stockholders | $-11,630,785 | $-22,080,903 | $-20,180,112 | $14,597,596 |
| Minority Interests | $349,803 | $1,627,854 | $512,653 | $348,500 |
| Tax Provision | $-2,383,806 | $-4,732,436 | $732,176 | $30,290 |
| Impairment Of Capital Assets | $0 | $0 | $22,046,705 | $0 |
| Restructuring And Mergern Acquisition | $0 | $0 | $347,523 | $-3,443,312 |
| Gain On Sale Of Security | $-9,330,358 | $-3,986,581 | $-990,457 | $2,329,414 |
| Provision For Doubtful Accounts | $2,357,424 | $4,714,523 | $1,005,113 | $3,813,634 |
| Research And Development | $127,023 | $134,840 | $126,372 | $205,843 |
| Selling General And Administration | $26,190,599 | $27,564,406 | $28,087,482 | $31,696,576 |
| Other Gand A | $4,609,321 | $4,021,431 | $3,878,774 | $3,893,105 |
| Insurance And Claims | $403,544 | $534,150 | $569,651 | $699,280 |
| Rent And Landing Fees | $1,624,923 | $1,887,763 | $1,940,527 | $1,953,229 |
| Salaries And Wages | $12,954,108 | $14,050,092 | $14,553,626 | $18,536,624 |
| Diluted Average Shares | - | $14,939,640 | $14,843,073 | $14,771,390 |
| Basic Average Shares | - | $14,939,640 | $14,843,073 | $14,771,390 |
Fetched: 2026-10-13
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $57,756,243 | $56,142,720 | $76,224,470 | $70,717,517 |
| Total Assets | $224,913,518 | $248,371,160 | $256,201,014 | $312,023,895 |
| Total Non Current Assets | $121,749,010 | $120,761,159 | $119,796,107 | $133,704,845 |
| Non Current Deferred Assets | $14,978,666 | $12,495,521 | $8,038,628 | $6,720,841 |
| Non Current Deferred Taxes Assets | $14,978,666 | $12,495,521 | $8,038,628 | $6,720,841 |
| Non Current Accounts Receivable | $1,560,108 | $137,772 | $1,370,224 | - |
| Investmentin Financial Assets | $39,736 | $699,280 | $625,997 | $835,423 |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | $39,736 | $699,280 | $625,997 | $835,423 |
| Goodwill And Other Intangible Assets | $71,391,067 | $73,150,504 | $72,005,990 | $92,558,053 |
| Current Assets | $103,164,508 | $127,610,001 | $136,404,907 | $171,805,029 |
| Restricted Cash | $662,476 | $428,623 | $3,146,272 | $4,529,525 |
| Prepaid Assets | $1,792,333 | $1,956,812 | $10,014,982 | $1,414,845 |
| Inventory | $35,196,559 | $40,819,462 | $34,619,091 | $47,714,554 |
| Receivables | $50,311,043 | $58,788,390 | $55,622,576 | $42,324,853 |
| Other Receivables | $41,265,021 | $28,394,944 | $21,632,739 | $4,101,228 |
| Loans Receivable | $2,009,250 | $13,307,168 | $13,201,315 | $20,959,515 |
| Accounts Receivable | $6,897,371 | $16,886,297 | $19,675,927 | $12,024,557 |
| Allowance For Doubtful Accounts Receivable | $-2,272,742 | $-2,524,183 | $-1,688,760 | $-536,430 |
| Gross Accounts Receivable | $9,170,113 | $19,410,480 | $21,364,687 | $12,560,987 |
| Cash Cash Equivalents And Short Term Investments | $15,202,097 | $25,616,714 | $33,001,986 | $75,821,253 |
| Cash And Cash Equivalents | $15,134,025 | $25,508,256 | $32,941,080 | $75,754,484 |
| Cash Equivalents | $403,218 | $19,720,222 | $2,058,431 | $13,105,559 |
| Cash Financial | $14,730,808 | $5,788,034 | $30,882,649 | $62,648,925 |
| Non Current Note Receivables | - | $0 | $6,008,207 | - |
| Debt | ||||
| Net Debt | $36,737,777 | $34,229,879 | $22,557,078 | - |
| Total Debt | $59,607,528 | $68,854,507 | $63,732,206 | $83,105,882 |
| Long Term Debt And Capital Lease Obligation | $25,713,773 | $44,679,671 | $33,496,074 | $39,991,530 |
| Long Term Debt | $19,366,185 | $37,123,081 | $26,773,279 | $32,467,184 |
| Current Debt And Capital Lease Obligation | $33,893,755 | $24,174,835 | $30,236,132 | $43,114,352 |
| Current Debt | $32,505,617 | $22,615,053 | $28,724,879 | $41,697,878 |
| Other Current Borrowings | $32,505,617 | $22,615,053 | $28,724,879 | $41,697,878 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $95,819,623 | $118,849,294 | $107,335,436 | $142,178,284 |
| Total Non Current Liabilities Net Minority Interest | $26,000,716 | $44,996,579 | $33,769,989 | $40,325,374 |
| Current Liabilities | $69,818,908 | $73,852,715 | $73,565,447 | $101,852,910 |
| Other Current Liabilities | $966,029 | $12,365,566 | $1,329,512 | $3,331,922 |
| Payables And Accrued Expenses | $34,959,123 | $37,312,313 | $40,670,943 | $51,431,129 |
| Payables | $29,335,243 | $32,639,480 | $36,600,005 | $47,982,280 |
| Other Payable | $7,140,670 | $7,384,620 | $11,052,014 | $6,922,125 |
| Accounts Payable | $22,194,573 | $25,254,860 | $25,547,991 | $41,060,156 |
| Current Deferred Liabilities | - | $0 | $1,328,860 | $3,975,507 |
| Equity | ||||
| Common Stock Equity | $129,147,310 | $129,293,224 | $148,230,461 | $163,275,570 |
| Total Equity Gross Minority Interest | $129,093,895 | $129,521,866 | $148,865,578 | $169,845,612 |
| Stockholders Equity | $129,147,310 | $129,293,224 | $148,230,461 | $163,275,570 |
| Other Equity Interest | $6,380,809 | - | - | $2,781,813 |
| Gains Losses Not Affecting Retained Earnings | $5,194,606 | $5,194,606 | $5,194,606 | $777,774 |
| Other Equity Adjustments | $5,194,606 | $5,194,606 | $5,194,606 | $777,774 |
| Retained Earnings | $-102,470,439 | $-90,407,775 | $-66,441,388 | $-46,135,229 |
| Long Term Equity Investment | $293,457 | $0 | - | $13,028,042 |
| Other | ||||
| Ordinary Shares Number | $17,809,769 | $15,360,946 | $14,843,073 | $14,843,073 |
| Share Issued | $17,809,769 | $14,905,846 | $14,843,073 | $14,843,073 |
| Tangible Book Value | $57,756,243 | $56,142,720 | $76,224,470 | $70,717,517 |
| Invested Capital | $181,019,112 | $189,031,358 | $203,728,619 | $237,440,633 |
| Working Capital | $33,345,600 | $53,757,286 | $62,839,460 | $69,952,119 |
| Capital Lease Obligations | $7,735,726 | $9,116,373 | $8,234,048 | $8,940,820 |
| Total Capitalization | $148,513,495 | $166,416,305 | $175,003,739 | $195,742,754 |
| Minority Interest | $-53,415 | $228,642 | $635,117 | $6,570,042 |
| Capital Stock | $220,042,333 | $214,506,392 | $209,477,242 | $205,851,212 |
| Common Stock | $220,042,333 | $214,506,392 | $209,477,242 | $205,851,212 |
| Employee Benefits | $286,943 | $316,907 | $273,915 | $333,844 |
| Long Term Capital Lease Obligation | $6,347,588 | $7,556,590 | $6,722,796 | $7,524,346 |
| Current Capital Lease Obligation | $1,388,138 | $1,559,782 | $1,511,253 | $1,416,474 |
| Current Accrued Expenses | $5,623,880 | $4,672,833 | $4,070,938 | $3,448,849 |
| Investments And Advances | $333,192 | $699,280 | $625,997 | $835,423 |
| Investmentsin Associatesat Cost | $293,457 | $0 | - | $13,028,042 |
| Goodwill | $71,391,067 | $73,150,504 | $72,005,990 | $92,558,053 |
| Net PPE | $33,485,977 | $34,278,082 | $31,747,059 | $33,590,527 |
| Accumulated Depreciation | $-23,295,768 | $-17,738,331 | $-13,083,412 | $-7,552,030 |
| Gross PPE | $56,781,746 | $52,016,413 | $44,830,471 | $41,142,558 |
| Other Properties | $14,418,786 | $14,196,658 | $11,736,638 | $10,998,925 |
| Machinery Furniture Equipment | $9,118,327 | $8,086,832 | $7,624,336 | $7,301,566 |
| Buildings And Improvements | $33,244,633 | $29,732,924 | $25,469,497 | $22,842,067 |
| Properties | $0 | $0 | $0 | $0 |
| Other Inventories | $18,565 | $1,635,996 | $267,726 | $2,073,087 |
| Finished Goods | $5,903,332 | $20,423,411 | $19,694,492 | $16,330,651 |
| Work In Process | $29,274,663 | $18,760,055 | $14,656,873 | $29,310,815 |
| Duefrom Related Parties Current | $139,400 | $199,980 | $1,112,595 | $5,239,553 |
| Other Short Term Investments | $68,072 | $108,458 | $60,906 | $66,769 |
| Current Deferred Revenue | - | - | $0 | $2,625,151 |
Fetched: 2026-10-13
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $4,329,218 | $-23,223,137 | $-18,320,685 | $10,267,726 |
| Operating Activities | ||||
| Operating Cash Flow | $5,485,132 | $-21,797,869 | $-17,467,674 | $16,697,716 |
| Cash Flow From Continuing Operating Activities | $5,485,132 | $-21,797,869 | $-17,467,674 | $16,697,716 |
| Operating Gains Losses | $1,033,775 | $-326,352 | $74,260 | $136,143 |
| Investing Activities | ||||
| Capital Expenditure | $-1,155,913 | $-1,425,268 | $-853,011 | $-6,429,990 |
| Investing Cash Flow | $-648,471 | $5,761,326 | $1,554,571 | $-46,411,424 |
| Cash Flow From Continuing Investing Activities | $-648,471 | $5,761,326 | $1,554,571 | $-46,411,424 |
| Net Other Investing Changes | $-340,683 | $7,054,685 | $3,492,167 | $-35,263,979 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $488,552 | $11,073,836 | $0 | $0 |
| Financing Cash Flow | $-15,196,560 | $8,616,422 | $-26,997,035 | $39,229,390 |
| Cash Flow From Continuing Financing Activities | $-15,196,560 | $8,616,422 | $-26,997,035 | $39,229,390 |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Net Common Stock Issuance | $488,552 | $11,073,836 | $0 | $0 |
| Common Stock Issuance | $488,552 | $11,073,836 | $0 | $0 |
| Net Other Financing Charges | - | $-31,919 | - | - |
| Other | ||||
| Repayment Of Debt | $-16,375,924 | $-58,853,530 | $-40,617,528 | $-40,954,954 |
| Issuance Of Debt | $6,888,577 | $61,375,433 | $20,429,925 | $85,813,761 |
| End Cash Position | $15,134,025 | $25,508,256 | $32,941,080 | $75,754,484 |
| Beginning Cash Position | $25,508,256 | $32,941,080 | $75,754,484 | $63,908,085 |
| Effect Of Exchange Rate Changes | $-14,331 | $-12,702 | $96,733 | $2,330,717 |
| Changes In Cash | $-10,359,899 | $-7,420,122 | $-42,910,138 | $9,515,682 |
| Interest Paid Cff | $-6,197,765 | $-4,947,399 | $-6,809,432 | $-5,629,417 |
| Net Issuance Payments Of Debt | $-9,487,346 | $2,521,903 | $-20,187,603 | $44,858,807 |
| Net Long Term Debt Issuance | $-9,487,346 | $2,521,903 | $-20,187,603 | $44,858,807 |
| Long Term Debt Payments | $-16,375,924 | $-58,853,530 | $-40,617,528 | $-40,954,954 |
| Long Term Debt Issuance | $6,888,577 | $61,375,433 | $20,429,925 | $85,813,761 |
| Interest Received Cfi | $305,833 | $0 | $275,217 | $0 |
| Net Business Purchase And Sale | $542,292 | $131,909 | $-1,367,944 | $-4,717,454 |
| Sale Of Business | $791,454 | $360,877 | $0 | $508,094 |
| Purchase Of Business | $-249,161 | $-228,968 | $-1,367,944 | $-5,225,548 |
| Net PPE Purchase And Sale | $-1,155,913 | $-1,425,268 | $-844,869 | $-6,429,990 |
| Sale Of PPE | $0 | $0 | $8,143 | $0 |
| Purchase Of PPE | $-1,155,913 | $-1,425,268 | $-853,011 | $-6,429,990 |
| Taxes Refund Paid | $99,665 | $-4,197,310 | $-2,478,911 | $-2,596,163 |
| Change In Working Capital | $6,148,910 | $-2,993,844 | $-29,695,143 | $-982,966 |
| Change In Payables And Accrued Expense | $-2,071,459 | $-1,634,368 | $-13,995,375 | $18,311,239 |
| Change In Payable | $-2,071,459 | $-1,634,368 | $-13,995,375 | $18,311,239 |
| Change In Account Payable | $-2,871,381 | $-2,898,739 | $-15,512,164 | $18,575,709 |
| Change In Inventory | $5,193,955 | $-5,679,575 | $13,095,463 | $-24,749,372 |
| Change In Receivables | $3,026,414 | $4,320,099 | $-28,795,231 | $5,455,167 |
| Changes In Account Receivables | $10,045,598 | $2,744,683 | $-7,651,369 | $-5,955,770 |
| Other Non Cash Items | $5,490,994 | $8,532,391 | $7,198,319 | $-906,100 |
| Stock Based Compensation | $791,128 | $742,924 | $844,217 | $2,901,019 |
| Unrealized Gain Loss On Investment Securities | $699,932 | $-120,835 | $215,288 | $56,021 |
| Asset Impairment Charge | $0 | $0 | $22,046,705 | $0 |
| Deferred Tax | $-2,383,806 | $-4,732,436 | $732,176 | $30,290 |
| Deferred Income Tax | $-2,383,806 | $-4,732,436 | $732,176 | $30,290 |
| Depreciation Amortization Depletion | $5,585,122 | $5,006,351 | $4,288,180 | $3,810,377 |
| Depreciation And Amortization | $5,585,122 | $5,006,351 | $4,288,180 | $3,810,377 |
| Depreciation | $5,585,122 | $5,006,351 | $4,288,180 | $3,810,377 |
| Pension And Employee Benefit Expense | $-29,964 | $42,993 | $-59,929 | $136,143 |
| Gain Loss On Sale Of PPE | $0 | $128,326 | $134,189 | $0 |
| Gain Loss On Sale Of Business | $1,063,740 | $-497,671 | $0 | $0 |
| Net Income From Continuing Operations | $-11,980,588 | $-23,708,757 | $-20,692,765 | $14,249,096 |
| Proceeds From Stock Option Exercised | - | - | $0 | $0 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Purchase Of Investment | - | - | - | $0 |
| Interest Received Cfo | - | - | - | - |
| Interest Paid Cfo | - | - | - | - |
| Change In Other Current Assets | - | - | - | - |
| Earnings Losses From Equity Investments | - | - | - | - |
Fetched: 2026-10-13